Impact of a special nuclear medicine scan(SPECT/ CT lymphoscintigraphy)in breast cancer radiation therapy planning to prevent limb swelling.
Phase 2
- Conditions
- Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast
- Registration Number
- CTRI/2023/11/059940
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age > 18 years
2. Unilateral breast cancer
3. Post Breast conservation surgery, stage I,IIA and IIB.
4. Patients planned for whole breast radiation F/B tumor bed
boost with pathologically N0 disease.
5. Adequate axillary dissection (10-12 nodes dissected)
6. Post op Histopathology-Invasive ductal carcinoma, negative
margins, Lymphovascular space invasion –ve, Extranodal
extension -ve
Exclusion Criteria
1. Bilateral breast cancer/ recurrent breast cancer
2. Previous radiation therapy to chest wall
3. Active infection in local site, i.e: arm.
4. Predisposing conditions to Lymphedema and lymphadenitis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method